inflammasom
emerg
critic
innat
sensor
host
immun
defens
pathogen
infect
metabol
syndrom
cellular
stress
cancer
metastasi
liver
assembl
inflammasom
activ
promot
matur
initi
pyroptot
cell
death
pyroptosi
exert
pleiotrop
effect
hepat
nk
cell
prime
faslmedi
cytotox
depend
respons
prevent
develop
liver
diseas
howev
consider
attent
attract
pathogen
role
inflammasom
variou
acut
chronic
liver
diseas
includ
viral
hepat
nanoparticleinduc
liver
injuri
alcohol
nonalcohol
steatohepat
review
summar
latest
advanc
physiolog
patholog
role
inflammasom
develop
inflammasomebas
therapeut
strategi
human
liver
diseas
innat
immun
system
wellknown
first
line
defens
pathogen
associ
molecular
pattern
pamp
deriv
microbi
pathogen
eg
bacteria
parasit
virus
damag
associ
molecular
pattern
damp
produc
host
cell
eg
cellular
stress
cytosol
dna
damag
inflammasom
critic
innat
immun
sensor
involv
maintain
cellular
health
respons
cytosol
pathogen
stress
signal
inflammasom
cytoplasm
multiprotein
complex
typic
compos
three
compon
sensor
molecul
consist
nodlik
receptor
nlr
absent
melanoma
pyrin
ii
adaptor
protein
iii
effector
molecul
upon
stimul
inflammasom
complex
assembl
process
cleavag
activ
proinflammatori
cytokin
cytosol
protein
gasdermin
gsdmd
cleav
gsdmd
form
pore
plasma
membran
induc
pyroptot
cell
death
permit
releas
extracellular
space
two
proinflammatori
cytokin
pyroptosi
exert
benefici
deleteri
effect
liver
discuss
review
liver
first
past
organ
continu
challeng
divers
microbi
particl
deriv
intestin
portal
circul
process
larg
number
cytosol
pathogen
sens
inflammasom
pivot
evok
adapt
immun
complet
clearanc
addit
hepatocyt
suscept
infect
variou
livertrop
virus
lead
pathogenesi
virusrel
liver
diseas
emerg
import
inflammasom
respons
viral
infect
point
anoth
area
involv
inflammasom
paradox
inflammasom
essenti
liver
defens
pathogen
danger
signal
excess
activ
inflammasom
promot
pathogenesi
variou
liver
diseas
tabl
thu
definit
understand
role
inflammasom
liver
essenti
develop
inflammasomebas
therapi
continu
exposur
orallyingest
antigen
intestinallyreleas
microbi
product
sensit
liver
variou
bacteri
parasit
infect
inflammasom
assembl
nlr
known
innat
immun
sensor
detect
cytosol
contamin
perturb
demonstr
defens
bacteri
infect
detect
bacteri
flagellin
two
bacteri
type
iii
secret
system
studi
livertrop
pathogen
chromobacterium
violaceum
shown
mice
suscept
infect
activ
inflammasom
process
product
prime
nk
cell
cytotox
clear
hepatocyt
replic
nich
addit
exogen
administr
protect
infect
c
violaceum
anoth
livertrop
bacteria
listeria
monocytogen
although
therapi
fulli
reduc
bacteri
burden
normal
level
consider
potenti
still
exist
activ
pathway
combin
therapi
counteract
bacteria
flagellin
addit
particip
liver
defens
bacteri
pathogen
inflammasom
also
identifi
control
parasit
infect
canon
inflammasom
process
cleavag
noncanon
inflammasom
implic
activ
loss
inflammasom
signal
knock
lead
higher
hepat
parasit
load
lower
surviv
mice
respons
trypanosoma
cruzi
cruzi
activ
highli
depend
lysosom
cathepsin
b
pharmacolog
inhibit
cathepsin
b
significantli
reduc
product
cruzi
infect
furthermor
lack
mice
accompani
downregul
hepat
cell
impli
inflammasomemedi
involv
promot
liver
adapt
immun
control
parasit
infect
find
line
previou
studi
show
import
differenti
cell
antigendriven
cell
thu
interplay
inflammasom
adapt
immun
system
defens
pathogen
infect
interest
aspect
futur
investig
viral
infect
typic
initi
cascad
innat
immun
respons
restrict
viral
spread
provok
adapt
immun
complet
remov
viru
innat
immun
sensor
inflammasom
promin
role
defens
hepat
viru
infect
mice
defici
suscept
mous
hepat
viru
mhv
infect
suggest
inflammasom
whole
protect
explor
identifi
inflammasomedepend
cytokin
requir
host
defens
mhv
receptor
defici
reduc
product
activ
cell
caus
elev
viral
replic
poor
surviv
mhvinfect
mice
despit
evid
involv
mhv
inhibit
mani
unansw
question
remain
includ
inflammasom
mediat
matur
inflammasom
activ
mhv
infect
beyond
cell
also
involv
promot
product
nk
cell
studi
perform
vitro
model
hepat
c
viru
hcv
replic
shown
monocyt
detect
hcvinfect
hepatocyt
respond
secret
inflammasomedepend
manner
subsequ
stimul
nk
cellderiv
caus
suppress
hcv
find
support
observ
higher
express
nk
cell
cell
popul
howev
protect
effect
seem
specif
monocyt
macrophagederiv
amplifi
inflammatori
respons
hcv
infect
thu
special
consider
requir
inflammasomerel
inflammatori
respons
appli
inflammasomebas
therapi
hepat
viru
infect
oxid
stress
induc
excess
reactiv
oxygen
speci
ro
emerg
hallmark
liver
injuri
process
nuclear
dna
mitochondri
dna
mtdna
releas
cytosol
act
damp
activ
innat
immun
recent
progress
made
identifi
inflammasom
broader
role
protect
hepatocyt
oxid
stressinduc
injuri
respond
mtdna
exampl
activ
increas
resist
oxid
stressinduc
liver
inflamm
damag
hemorrhag
shock
resuscit
hsr
followup
studi
shown
activ
mediat
inflammasom
defici
reduc
product
aggrav
hepatocellular
cell
death
consid
inflammasom
intracellular
receptor
recogn
dysfunct
dna
investig
demonstr
interact
immunogen
dna
sensor
high
mobil
group
box
facilit
hepatoprotect
effect
anoth
interest
find
inflammasomemedi
upregul
express
initi
autophagi
clear
damag
mitochondria
hepatocyt
thu
reduc
gener
ro
degrad
damag
mtdna
togeth
find
suggest
inflammasom
crossroad
innat
immun
sensor
benefici
autophagi
protect
oxid
stressinduc
liver
injuri
addit
emerg
import
hepatocyt
nonimmun
cell
type
regul
immun
respons
anoth
import
area
investig
one
addit
organspecif
featur
liver
make
sensit
inflammasom
liver
serv
second
largest
storehous
lipid
next
adipos
tissu
emerg
evid
indic
inflammasom
critic
regul
suppress
hepat
lipid
deposit
mice
defici
spontan
develop
hepat
steatosi
syndrom
aggrav
highfat
diet
hfd
mut
activ
mutat
mice
devoid
lipid
vacuol
liver
antiobes
abil
inflammasom
appear
depend
knockout
revers
protect
effect
addit
exogen
administr
counteract
steatohepat
mice
upon
hfd
highlight
import
signal
control
metabol
syndrom
mechanist
perspect
studi
also
rais
interest
question
trigger
lead
activ
inflammasom
metabol
liver
diseas
need
clearli
elucid
anoth
two
inflammasom
also
report
neg
regul
progress
nonalcohol
fatti
liver
diseas
nafld
mice
develop
exacerb
hepat
steatosi
microbiom
dysbiosi
either
hfd
methioninecholinedefici
diet
mcdd
interestingli
microbiom
dysbiosi
mice
transfer
cohous
wide
type
wt
mice
strongli
correl
sever
hepat
disord
possibl
explan
exposur
hfd
mcdd
alter
gut
microbiota
composit
function
increas
transloc
bacteri
product
liver
thu
aggrav
hepat
steatosi
inflamm
term
gutliv
axi
inflammasom
recogn
potent
modul
maintain
gut
homeostasi
one
group
microbialderiv
metabolit
trigger
activ
axi
subsequ
lead
proteolyt
process
elicit
antimicrobi
peptid
synthesi
control
composit
gut
microbiota
also
upregul
signal
promot
wound
heal
uncov
interact
inflammasom
hepat
lipid
metabol
provid
novel
therapeut
target
treatment
hepat
steatosi
inflammasom
recogn
import
tumor
control
directli
activ
pyroptot
cell
death
secret
deathinduc
cytokin
evid
inflammasom
suppress
hepat
tumor
growth
come
studi
show
colorect
cancer
crc
metastat
liver
tumor
burden
exacerb
mice
tumorsuppress
effect
inflammasom
liver
crc
metastasi
highli
depend
promot
matur
hepat
nk
cell
prime
faslmedi
cytotox
studi
provid
insight
innat
immun
circul
crcinduc
activ
inflammasom
kupffer
celland
nk
cellmedi
cytotox
addit
prime
tumoricid
activ
hepat
nk
cell
inflammasom
also
induc
pyroptosi
control
prolifer
hepatocellular
carcinoma
hcc
cell
downregul
express
inflammasom
hcc
tissu
correl
aggrav
carcinoma
reconstitut
inflammasom
dramat
revers
malign
phenotyp
hcc
find
highlight
signific
inflammasom
prevent
hepat
tumor
growth
also
exert
procarcinogen
effect
gastric
prostat
cancer
indict
protect
role
inflammasom
cancer
develop
may
organ
cell
specif
ald
trigger
excess
alcohol
consumpt
progress
fatti
liver
sever
cirrhosi
liver
failur
hcc
involv
inflammasom
ald
demonstr
robust
express
alcoholf
mice
liver
inflamm
steatosi
dramat
attenu
mice
proinflammatori
cytokin
lead
recruit
invari
natur
killer
inkt
cell
promot
influx
neutrophil
exacerb
hepat
beyond
regul
activ
inflammasom
also
facilit
occurr
pyroptosi
confirm
pyroptosi
determin
protein
gsdmd
activ
liver
mice
suffer
ald
adenovir
express
cleav
gsdmd
hepatocyt
aggrav
sever
liver
inflamm
damag
interestingli
one
type
mirna
recent
demonstr
suppress
pyroptosi
ald
hepatocyt
specif
express
lentiviru
deliveri
directli
inhibit
interact
thioredoxininteract
protein
lead
attenu
pyroptosi
decreas
incid
ald
report
provid
evid
inflammasom
pathogen
develop
ald
howev
trigger
initi
activ
remain
determin
nash
progress
type
nafld
chronic
hepat
damag
inflamm
hepatocellular
damag
associ
toxic
effect
induc
accumul
lipid
satur
fatti
acid
ceramid
palmit
cholesterol
crystal
emerg
evid
accumul
inflammasom
activ
toxic
lipid
pathogen
mechan
develop
nash
murin
model
increas
level
gsdmd
observ
liver
patient
nash
beyond
amplifi
inflammatori
respons
activ
inflammasom
also
promot
liver
fibrogenesi
nash
blockad
improv
nash
patholog
simultan
suppress
liver
inflamm
fibrosi
latest
research
demonstr
import
gsdmdmediat
pyroptosi
process
nash
gsdmd
mice
develop
remark
attenu
steatohepat
compar
wt
mice
confirm
detriment
role
inflammasom
signal
pathway
nash
one
potenti
neg
regul
inflammasom
nash
autophagi
defect
autophagi
caus
accumul
dysfunct
mitochondria
increas
product
ro
requir
activ
inflammasom
contrast
induct
autophagi
ezetimib
dampen
inflammasom
activ
amelior
hepat
lipid
accumul
inflamm
mcd
find
impli
benefici
role
autophagi
nash
via
suppress
inflammasom
contrari
studi
suggest
promot
nash
experiment
research
shown
defici
lead
increas
bacteremia
aggrav
nash
divers
function
explain
evid
differ
activ
inflammasom
differ
organ
nash
liver
express
inflammasom
upregul
respons
pathogenesi
nash
downregul
gut
protect
alter
intestin
bacteria
observ
suggest
liverspecif
blockad
inflammasom
necessari
afford
improv
liver
inflamm
steatosi
devoid
gut
microbi
dysbiosi
hepat
virus
preferenti
infect
hepatocyt
caus
liver
inflamm
high
mortal
among
approxim
attribut
chronic
infect
induc
hepat
b
viru
hbv
hcv
sever
studi
suggest
inflammasom
central
player
pathophysiolog
viral
hepat
hepat
express
significantli
higher
patient
activ
untreat
chronic
hbv
chronic
remiss
addit
strong
correl
demonstr
level
sever
liver
inflamm
hbv
patient
impli
potenti
drive
forc
hbvinduc
viral
hepat
inflammasom
also
identifi
hcv
infect
observ
upregul
express
signal
pathway
monocyt
macrophag
hcv
hcv
infect
inflammasom
serv
either
benefici
detriment
role
one
hand
kupffer
cell
identifi
primari
cell
sourc
chronic
hcv
patient
product
kupffer
cell
associ
amplifi
inflammatori
respons
addit
inflammasom
stimul
lipid
droplet
format
hepatocyt
promot
morphogenesi
replic
hcv
thu
contribut
pathogenesi
liver
diseas
hand
activ
monocyt
stimul
product
prime
resist
hcv
infect
observ
suggest
inflammasom
deriv
macrophag
hepatocyt
monocyt
exert
differ
function
requir
indepth
investig
potenti
link
inflammasom
activ
cell
hcv
infect
optim
physicochem
properti
nanoparticl
make
wide
use
diseas
diagnosi
imag
treatment
clinic
applic
greatli
hamper
fulmin
hepat
liver
injuri
tremend
effort
made
clarifi
underl
mechan
recent
studi
identifi
pyroptosi
serv
critic
pathogen
factor
liver
injuri
induc
multipl
nanoparticl
includ
rareearth
oxid
reo
quantum
dot
mesopor
silica
exampl
reo
treatment
activ
inflammasom
lead
occurr
pyroptosi
secret
kupffer
cell
suppress
gsdmd
knockdown
coat
reo
small
peptid
inhibit
activ
via
reduc
ro
gener
calcium
influx
thu
attenu
reoelicit
inflamm
confirm
pathogen
role
reoinduc
toxic
detail
insight
mechan
shown
sustain
activ
respons
reo
mediat
lysosom
damag
massiv
releas
cathepsin
b
collect
studi
implic
involv
inflammasomemedi
pyroptosi
nanoparticleinduc
liver
injuri
may
provid
novel
strategi
control
nanoparticlesmedi
advers
effect
liver
fibrosi
pathogen
result
chronic
liver
diseas
ash
nash
character
deposit
extracellular
matrix
ecm
hepat
stellat
cell
hsc
primari
cell
storag
ecm
multipl
function
chang
hsc
caus
inflammasom
includ
suppress
chemotaxi
upregul
collagen
transform
growth
function
confirm
studi
knock
induc
activ
hsc
subsequ
accumul
ecm
protein
fibrogenesi
revers
therapi
indic
regul
inflammasom
pathway
instead
promot
fibrogenesi
addit
direct
effect
innat
immun
inflammasom
essenti
role
shape
adapt
immun
respons
liver
fibrosi
particular
promot
differenti
cell
secret
critic
proinflammatori
cytokin
amplifi
figur
pathogen
role
inflammasom
liver
diseas
gutderiv
pamp
lipopolysaccharid
lp
activ
nuclear
factor
kappa
b
signal
pathway
promot
express
inflammasom
liver
activ
seriou
danger
signal
cholesterol
crystal
ethanol
reo
nanoparticl
excess
alcohol
consumpt
stimul
gener
ro
facilit
cleavag
txnip
contribut
assembl
inflammasom
activ
inflammasom
respons
hcv
infect
requir
recognit
tolllik
clathrinmedi
endocytosi
pyroptosi
featur
gsdmd
pore
membran
allow
releas
extracellular
space
inflammasom
cooper
contribut
pathogenesi
liver
fibrosi
frontier
immunolog
wwwfrontiersinorg
inflamm
respons
perpetu
liver
fibrosi
driven
inflammasom
activ
collect
inflammasom
pathway
appear
central
pathogenesi
liver
fibrosi
uncov
link
may
open
avenu
novel
therapeut
liver
fibrosi
summari
inflammasom
central
compon
innat
immun
system
protect
liver
pathogen
infect
metabol
syndrom
oxid
stress
tumor
growth
howev
excess
immun
respons
mediat
inflammasom
may
promot
pathogenesi
variou
liver
diseas
dual
function
inflammasom
pose
challeng
design
inflammasomebas
therapi
therefor
import
better
understand
precis
mechan
underli
activ
inflammasom
date
patholog
role
inflammasom
liver
diseas
extens
studi
figur
futur
investig
need
elucid
hepat
import
inflammasom
may
hope
provid
new
target
treatment
liver
diseas
jl
dj
conceiv
review
jl
wrote
manuscript
dj
revis
manuscript
author
read
approv
final
version
manuscript
